Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/28/2010US20100273866 Diagnosis and treatment of cancer: i
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273858 Compositions comprising stat5 sirna and methods of use thereof
10/28/2010US20100273856 Screening of micro-rna cluster inhibitor pools
10/28/2010US20100273855 Compositions and methods of treating cancer
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273848 Iminopyrrolidone thiol amino acid conjugates, pharmaceutical compositions and methods for the treatment of cancer
10/28/2010US20100273846 Method for treating proliferative disorders associated with mutations in c-met
10/28/2010US20100273843 Heterocyclic self-immolative linkers and conjugates
10/28/2010US20100273840 Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents
10/28/2010US20100273831 Fluoro alkyl substituted benzimidazole cannabinoid agonists
10/28/2010US20100273828 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273819 3,3'-Spiroindolinone Derivatives
10/28/2010US20100273818 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
10/28/2010US20100273817 Anti-cancer cyclopenta(g)quinazoline compounds
10/28/2010US20100273812 Diazo bicyclic smac mimetics and the uses thereof
10/28/2010US20100273811 N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and Salts Thereof
10/28/2010US20100273808 Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
10/28/2010US20100273806 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
10/28/2010US20100273804 Pyridazine derivatives useful as fungicides and for the treatment of cancer
10/28/2010US20100273803 Oral Formulations for Tetrapyrrole Derivatives
10/28/2010US20100273802 New purine derivatives having, in particular, anti-proliferative properties, and their biological uses
10/28/2010US20100273800 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
10/28/2010US20100273799 Small molecule inhibitors of mdm2 and the uses thereof
10/28/2010US20100273796 2-benzylpyridazinone derivatives as met kinase inhibitors
10/28/2010US20100273793 6-ARYL/HETEROALKYLOXY BENZOTHIAZOLE AND BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, APPLICATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE IN PARTICULAR AS c-MET INHIBITORS
10/28/2010US20100273788 Fused heterocyclic derivative and use thereof
10/28/2010US20100273774 Indolymaleimide derivatives
10/28/2010US20100273764 Inhibitors of pi3 kinase and/or mtor
10/28/2010US20100273763 Organometallic complexes as therapeutic agents
10/28/2010US20100273759 Progesterone antagonists
10/28/2010US20100273754 Organic compounds
10/28/2010US20100273751 Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/28/2010US20100273745 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
10/28/2010US20100273734 Derivatives of Hyaluronic Acids
10/28/2010US20100273732 Combination methods of treating cancer
10/28/2010US20100273731 Medium-Chain Length Fatty Acids, Salts and Triglycerides in Combination with Gemcitabine for Treatment of Pancreatic Cancer
10/28/2010US20100273728 Formulations For The Oral Administration of Therapeutic Agents and Related Methods
10/28/2010US20100273719 Use of somatostatin analogs in meningioma
10/28/2010US20100273711 Individualized cancer treatments
10/28/2010US20100273707 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100273701 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
10/28/2010US20100273700 Use of a peptide as a therapeutic agent
10/28/2010US20100273658 Methods for Assaying Gene Imprinting and Methylated CpG Islands
10/28/2010US20100272824 Compositions and methods for preventing and monitoring disease
10/28/2010US20100272822 Nanocell drug delivery system
10/28/2010US20100272809 Microparticles comprising somatostatin analogues
10/28/2010US20100272789 External medicine for treatment or prevention
10/28/2010US20100272785 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles
10/28/2010US20100272779 Progesterone-containing compositions and devices
10/28/2010US20100272773 Use of Drug Polymorphs to Achieve Controlled Drug Delivery From a Coated Medical Device
10/28/2010US20100272772 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo
10/28/2010US20100272756 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
10/28/2010US20100272751 Truncated l1 protein of human papillomavirus type 18
10/28/2010US20100272742 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
10/28/2010US20100272735 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
10/28/2010US20100272734 Compositions and methods for increasing muscle growth
10/28/2010US20100272733 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
10/28/2010US20100272732 Emp2 antibodies and their therapeutic uses
10/28/2010US20100272730 Antigenic GM-CSF Peptides And Antibodies To GM-CSF
10/28/2010US20100272729 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272728 Mammalian tumor susceptibility gene products and their uses
10/28/2010US20100272726 Assays, methods and means
10/28/2010US20100272723 Optimized Antibodies that Target CD19
10/28/2010US20100272721 Treatment of cancer
10/28/2010US20100272717 Combinations of therapeutic agents for treating cancer
10/28/2010US20100272712 Jnk3 as a target for the treatment of angiogenesis-related diseases
10/28/2010US20100272710 Compositions and methods for treating and preventing aging-associated diseases
10/28/2010US20100272692 Anticancer composition comprising plant stem cell line derived from taxus cambium or procambium
10/28/2010US20100272691 Viruses
10/28/2010US20100272687 Mutant viruses and uses thereof
10/28/2010US20100272686 Oncolytic virus
10/28/2010US20100272678 Anti-cancer drugs, and uses relating for malignant melanoma and other cancers
10/28/2010US20100272676 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
10/28/2010US20100272659 Recombinant preparation of selected bromelain fractions
10/28/2010US20100272643 Procaspase 8-Mediated Disease Targeting
10/28/2010US20100272640 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
10/28/2010US20100272637 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
10/28/2010US20100272636 Anti-CD74 Immunoconjugates and Methods of Use
10/28/2010DE102009018537A1 Verwendung von mit Chinazolinon-Derivat oberflächen-modifizierten Silikonformkörpern Use of quinazolinone derivative with surface-modified silicone moldings
10/28/2010CA2792953A1 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
10/28/2010CA2791947A1 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
10/28/2010CA2761108A1 Heterocyclic compounds as mek inhibitors
10/28/2010CA2759793A1 Preparation and application of the new antibacterial and anticancer compounds and their derivatives
10/28/2010CA2759724A1 Methods of treatment for solid tumors
10/28/2010CA2759655A1 Heteroaryl compounds and uses thereof
10/28/2010CA2759597A1 Method for the treatment of acute myeloid leukemia
10/28/2010CA2759595A1 Thia-triaza-cyclopentazulenes as pi3-kinases inhibitors for the treatment of cancer
10/28/2010CA2759506A1 Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
10/28/2010CA2759474A1 Prodrugs based on gemcitabine structure and synthetic methods and applications thereof
10/28/2010CA2759368A1 5-alkynyl-pyridines
10/28/2010CA2759146A1 Antibody containing igg2 having amino acid mutation introduced therein
10/28/2010CA2759131A1 Novel 7-deazapurine nucleosides for therapeutic uses
10/28/2010CA2759129A1 Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
10/28/2010CA2759060A1 A drug composition for treating tumor with polymeric micelle encapsulating anti-neoplastic
10/28/2010CA2758640A1 3,3'-spiroindolinone derivatives and their use for cancer
10/28/2010CA2757764A1 Cancer antigen helper peptide
1 ... 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 ... 2211